Colorectal Cancer

New First-Line Chemotherapy Treatment Developed for Metastatic Disease

Published in Cancer Weekly, October 24th, 2000

In an international study published in the September 28, 2000, issue of the New England Journal of Medicine, researchers at Memorial Sloan-Kettering Cancer Center report the development of a new chemotherapy regimen for first line treatment for patients with metastatic colorectal cancer.

This disease is the second leading cause of cancer death, with an estimated 56,300 men and women expected to die this year in the United States alone. The study showed patients receiving the new regimen had improved tumor response rates and improved overall survival as compared to those on standard treatment.

The combination therapy, developed by Dr....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-10-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry